Drug Delivery Systems Market size was over USD 47.47 billion in 2024 and is expected to exceed USD 122.69 billion by the end of 2037, growing at over 8.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of drug delivery systems is evaluated at USD 50.58 billion.
The growth of this market can be attributed to the increased availability of vaccines for different types of diseases such as typhoid, tuberculosis, influenza, hepatitis, and others. According to a report, in 2021 the global coverage of hepatitis B is around 80% for Haemophilus influenza type B vaccine nearly 71% and nearly 80% of infants all over the world received polio vaccination.
The cases of chronic disease are constantly rising owing to lifestyle disorders, unhealthy eating habits, and sleeping disorders. According to the World Health Organization, about 17.9 million people die of cardiovascular disease every year, and cardiovascular is the primary reason for most of the deaths in the world.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
8.1% |
|
Base Year Market Size (2024) |
USD 47.47 billion |
|
Forecast Year Market Size (2037) |
USD 122.69 billion |
|
Regional Scope |
|
Indication (Diabetes, Cardiovascular Disease, Multiple Sclerosis, Asthma COPD)
Drug delivery systems market from the diabetes market is anticipated to expand and register the highest CAGR of 33% over the coming years. The increasing number of diabetes patients worldwide may be attributed to the segment's expansion. According to the World Health Organisation, there are 422 million diabetics worldwide. Moreover, the high utilization of insulin injections by diabetes patients is also expected to boost the growth of this segment in the projected period.
Type (Transdermal, Inhalation, Injectable)
The injectable sector is anticipated to see the most market growth over the next years. This is attributable to individuals becoming more aware of wearable injectable medicine delivery methods. Furthermore, it is anticipated that segmental expansion will be aided in the coming years by the expanding immunization campaign that is increasing syringe usage globally. Also it is anticipated that until vaccines are completed, the growing need for needles and syringes will fuel segmental expansion.
Our in-depth analysis of the global market includes the following segments:
|
Type |
|
|
Device Type |
|
|
Indication |
|
|
Distribution Channel |
|
North America Market Forecasts
By the end of 2037, the North American drug delivery systems market is anticipated to have the greatest revenue share of 35% worldwide. Longer hospital stays in the area are likely to fuel the market expansion for drug delivery systems in North America during the anticipated time frame. According to a paper published in April 2021, Canada experienced approximately 3 million acute inpatient hospitalizations in the years 2019–2020. The region's delivery systems are expected to improve as a result of these hospitalizations.
Europe Market Statistics
On the other side, Europe is anticipated to maintain a sizable market share during the projection period. This is explained by the region's growing recognition of cutting-edge medication delivery methods and acceptance of cutting-edge technology. The launch of novel medication delivery systems by important stakeholders is also projected to fuel regional market expansion, as are clinical studies for crucial governance permissions for innovative medicines.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?